» Authors » Andreas K O Aslund

Andreas K O Aslund

Explore the profile of Andreas K O Aslund including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 398
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Snipstad S, Sulheim E, Aslund A, Hyldbakk A, Wagbo A, Klinkenberg G, et al.
Eur J Pharm Sci . 2024 May; 199:106804. PMID: 38763448
Lung cancer is one of the most common cancers and a leading cause of death, with poor prognosis and high unmet clinical need. Chemotherapy is a common part of the...
2.
Valsalakumari R, Pandya A, Prasmickaite L, Kvalvaag A, Myrann A, Aslund A, et al.
Int J Nanomedicine . 2024 Apr; 19:3009-3029. PMID: 38562610
Background: Biodegradable poly(alkyl cyanoacrylate) (PACA) nanoparticles (NPs) are receiving increasing attention in anti-cancer nanomedicine development not only for targeted cancer chemotherapy, but also for modulation of the tumor microenvironment. We...
3.
Ilkhanizadeh S, Gracias A, Aslund A, Back M, Simon R, Kavanagh E, et al.
ACS Appl Bio Mater . 2023 Aug; 6(9):3790-3797. PMID: 37647213
There is an urgent need for simple and non-invasive identification of live neural stem/progenitor cells (NSPCs) in the developing and adult brain as well as in disease, such as in...
4.
Sulheim E, WiderOe M, Back M, Nilsson K, Hammarstrom P, Nilsson L, et al.
J Alzheimers Dis . 2023 Apr; 93(2):411-419. PMID: 37038807
Background: Early detection of amyloid-β (Aβ) aggregates is a critical step to improve the treatment of Alzheimer's disease (AD) because neuronal damage by the Aβ aggregates occurs before clinical symptoms...
5.
Hyldbakk A, Fleten K, Snipstad S, Aslund A, Davies C, Flatmark K, et al.
Nanomedicine . 2023 Jan; 48:102656. PMID: 36646195
Colorectal and ovarian cancers frequently develop peritoneal metastases with few treatment options. Intraperitoneal chemotherapy has shown promising therapeutic effects, but is limited by rapid drug clearance and systemic toxicity. We...
6.
Hyldbakk A, Morch Y, Snipstad S, Aslund A, Klinkenberg G, Nakstad V, et al.
Int J Pharm X . 2022 Jul; 4:100124. PMID: 35898812
Poly (alkyl cyanoacrylate) (PACA) polymeric nanoparticles (NPs) are promising drug carriers in drug delivery. However, the selection of commercially available alkyl cyanoacrylate (ACA) monomers is limited, because most monomers were...
7.
Aslund A, Vandebriel R, Caputo F, de Jong W, Delmaar C, Hyldbakk A, et al.
Drug Deliv Transl Res . 2022 Apr; 12(9):2114-2131. PMID: 35426570
Biodistribution of nanoencapsulated bioactive compounds is primarily determined by the size, shape, chemical composition and surface properties of the encapsulating nanoparticle, and, thus, less dependent on the physicochemical properties of...
8.
Mpambani F, Aslund A, Lerouge F, Nystrom S, Reitan N, Huuse E, et al.
ACS Appl Bio Mater . 2022 Jan; 1(2):462-472. PMID: 35016367
Real time detection of Amyloid β (Aβ) deposits at an early stage may lead to faster and more conclusive diagnosis of Alzheimer's disease (AD) and can facilitate the follow up...
9.
Pandya A, Iversen T, Moestue S, Grinde M, Morch Y, Snipstad S, et al.
Nanomaterials (Basel) . 2021 Apr; 11(5). PMID: 33924869
We have investigated the biodistribution and tumor macrophage infiltration after intravenous injection of the poly(alkyl cyanoacrylate) nanoparticles (NPs): PEBCA (poly(2-ethyl-butyl cyanoacrylate), PBCA (poly(n-butyl cyanoacrylate), and POCA (poly(octyl cyanoacrylate), in mice....
10.
Germain M, Caputo F, Metcalfe S, Tosi G, Spring K, Aslund A, et al.
J Control Release . 2020 Jul; 326:164-171. PMID: 32681950
The situation of the COVID-19 pandemic reminds us that we permanently need high-value flexible solutions to urgent clinical needs including simplified diagnostic technologies suitable for use in the field and...